Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Sex Transm Infect ; 95(2): 129-132, 2019 03.
Artículo en Inglés | MEDLINE | ID: mdl-30154157

RESUMEN

OBJECTIVES: Trichomonas vaginalis (TV) infection is the most common non-viral STI globally and can result in adverse pregnancy outcomes and exacerbated HIV acquisition/transmission. Nucleic acid amplification tests (NAATs) are the most sensitive diagnostic tests, with high specificity, but TV NAATs are rarely used in Brazil. We investigated the TV prevalence and compared the performance of the US Food and Drug Association-cleared Aptima TV assay with microscopy (wet mount and Gram-stained) and culture for TV detection in women in Pelotas, Brazil in an observational study. METHODS: From August 2015 to December 2016, 499 consecutive asymptomatic and symptomatic sexually active women attending a Gynaecology and Obstetrics Outpatient Clinic were enrolled. Vaginal fluid and swab specimens were collected and wet mount microscopy, Gram-stained microscopy, culture and the Aptima TV assay performed. RESULTS: The median age of enrolled women was 36.5 years (range: 15-77). The majority were white, had a steady sexual partner and low levels of education. The TV detection rate was 4.2%, 2.4%, 1.2% and 0% using the Aptima TV assay, culture, wet mount microscopy and Gram-stained microscopy, respectively. The sensitivity of culture and wet mount microscopy was only 57.1% (95% CI 36.5 to 75.5) and 28.6% (95% CI 13.8 to 50.0), respectively. CONCLUSIONS: A 4.2% positivity rate of T. vaginalis was found among women in Pelotas, Brazil and the routine diagnostic test (wet mount microscopy) and culture had low sensitivities. More sensitive diagnostic tests (NAATs) and enhanced testing of symptomatic and asymptomatic at-risk women are crucial to mitigate the transmission of TV infection, TV-associated sequelae and enhanced HIV acquisition and transmission.


Asunto(s)
Microscopía/normas , Juego de Reactivos para Diagnóstico/normas , Tricomoniasis/diagnóstico , Vaginitis por Trichomonas/diagnóstico , Trichomonas vaginalis/aislamiento & purificación , Adolescente , Adulto , Anciano , Brasil/epidemiología , Ensayo de Unidades Formadoras de Colonias/métodos , Ensayo de Unidades Formadoras de Colonias/normas , Errores Diagnósticos , Femenino , Violeta de Genciana , Humanos , Microscopía/métodos , Persona de Mediana Edad , Fenazinas , Prevalencia , Sensibilidad y Especificidad , Tricomoniasis/epidemiología , Vaginitis por Trichomonas/epidemiología , Estados Unidos , United States Food and Drug Administration , Adulto Joven
2.
Transfusion ; 53(3): 668-78, 2013 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-22845003

RESUMEN

BACKGROUND: Ex vivo expansion of hematopoietic stem and progenitor cells has become a priority in the experimental hematology arena. In this study we have obtained different hematopoietic cell populations from umbilical cord blood and simultaneously assessed their proliferation and expansion kinetics. Our main goal was to determine which one of these cell populations would be more suitable for clinical-grade ex vivo expansion. STUDY DESIGN AND METHODS: By using immunomagnetic-negative selection and cell sorting, five cell populations were obtained: unseparated mononuclear cells (MNCs; I); two lineage-negative cell populations, one enriched for CD34+ CD38+ cells (II) and the other enriched for CD34+ CD38- cells (III); and two CD34+ cell fractions purified by fluorescence-activated cell sorting, one containing CD34+ CD38+ cells (IV) and the other containing CD34+ CD38- cells (V). The kinetics of such populations were analyzed in both relative and absolute terms. RESULTS: No expansion was observed in Population I; in contrast, significant increments in the numbers of both progenitor and stem cells were observed in cultures of Populations II to V. Population V (reaching 12,800-fold increase in total cells; 1280-fold increase in CD34+ cells; 490-fold increase in colony-forming cells; and 12-fold increase in long-term culture-initiating cells) showed the highest proliferation and expansion potentials. CONCLUSION: Our study suggests that the cell fraction containing greater than 98% CD34+ CD38- cells would be the ideal one for large-scale ex vivo expansion; however, based on our data, it seems that, except for MNCs, all other cell populations could also be used as input cell fractions.


Asunto(s)
Técnicas de Cultivo de Célula , Proliferación Celular , Sangre Fetal/citología , Células Madre Hematopoyéticas/citología , Antígenos CD34/metabolismo , Recuento de Células , Técnicas de Cultivo de Célula/métodos , Separación Celular , Células Cultivadas , Conducta de Elección , Ensayo de Unidades Formadoras de Colonias/métodos , Sangre Fetal/fisiología , Células Madre Hematopoyéticas/metabolismo , Células Madre Hematopoyéticas/fisiología , Humanos , Cultivo Primario de Células/métodos , Factores de Tiempo
3.
Int Endod J ; 44(1): 59-64, 2011 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-20880134

RESUMEN

AIM: To compare and contrast two colorimetric assays used for the measurement of proliferation using two dental pulp cell types: dental pulp stem cells (DPSC) and human dental pulp fibroblasts (HDPF). METHODOLOGY: Dental pulp stem cells or HDPF were seeded at 0.25×10(4) cells per well in 96-well plates. Cell proliferation was evaluated after 24-72h. At the end of the experimental period, the sulforhodamine B (SRB) assay or a water-soluble tetrazolium salt (WST-1) assay was performed. Optical densities were determined in a microplate reader (Genius; TECAN). Data were analysed by Student's t-test (comparison between cell types) and one-way anova followed by Tukey test (time-point intervals). Pearson' correlation tests were performed to compare the two assays for each cell line. RESULTS: Both assays showed that DPSC had higher proliferation rates than HDPF. A positive significant correlation between the two colorimetric assays tested for both cell types DPSC (Pearson's correlation coefficient=0.847; P<0.05) and HDPF (Pearson's correlation coefficient=0.775; P<0.05). CONCLUSION: Both tests demonstrated similar trends of cell proliferation, and thus are both appropriate for the evaluation of DPSC and HDPF. The choice of assay is therefore one of the practical applications. SRB stained plates can be dried and stored so may have utility in laboratories where data may require review or when access to analytical equipment is limited. WST-1 assays have the benefit of both ease and speed and may have utility in laboratories requiring either high throughput or rapid analyses.


Asunto(s)
Células Madre Adultas/citología , Colorimetría/métodos , Pulpa Dental/citología , Fibroblastos/citología , Análisis de Varianza , Proliferación Celular , Células Cultivadas , Ensayo de Unidades Formadoras de Colonias/métodos , Colorantes/metabolismo , Humanos , Rodaminas/metabolismo , Estadísticas no Paramétricas , Sales de Tetrazolio/metabolismo
4.
São Paulo; s.n; s.n; 2011. 135 p. tab, graf, ilus.
Tesis en Portugués | LILACS | ID: biblio-847636

RESUMEN

Os antígenos cancer-testis (CT) são proteínas imunogênicas expressas em tecido gametogênico e em diferentes tipos de tumor, sendo considerados candidatos promissores para a imunoterapia do câncer. Entretanto, pouco se sabe sobre a função desses antígenos na tumorigênese. Em 2006, identificamos CTSP-1 como um novo antígeno CT, frequentemente expresso em vários tumores. Nesse trabalho, investigamos a função de CTSP-1 por meio da identificação de proteínas expressas em tumores de próstata e que são capazes de interagir fisicamente com esse antígeno. Demonstramos que CTSP-1 interage com a proteína CTCF em ensaios de duplo-híbrido em leveduras, pulldown e de co-localização e, em seguida, analisamos o impacto da superexpressão de CTSP-1 no controle da expressão de genes CT mediada por CTCF e na progressão do ciclo celular. Utilizando o CT NY-ESO-1 como modelo, demonstramos que a superexpressão de CTSP-1 não altera os níveis endógenos de NY-ESO-1 na linhagem celular tumoral H1299. Por outro lado, observamos que a superexpressão de CTSP-1 48h após as transfecções em H1299 induz um bloqueio do ciclo em G0/G1, reduzindo a capacidade clonogênica dessas células por um mecanismo dependente dos níveis de expressão de CTSP-1. Resultados semelhantes não foram observados em ensaios com clones superexpressando CTSP-1 estavelmente, o que sugere que eles tenham se originado de células que conseguiram escapar do bloqueio em G0/G1. Resultados preliminares sugerem que a redução da capacidade clonogênica das células H1299 que superexpressam CTSP-1 48h após as tansfecções não está associada à ocorrência de morte por apoptose


Cancer-testis (CT) antigens are immunogenic proteins expressed in gametogenic tissues and in different histological types of tumors, being considered promising candidates for cancer immunotherapy. However, little is known about their role in tumorigenesis. In 2006, we identified CTSP-1 as a novel CT antigen, frequently expressed in different types of tumors. In this work, we investigated the functional role of CTSP-1 through the identification of proteins expressed in prostate tumors and that physically interact with this tumor antigen. We demonstrate that CTSP-1 interacts with the CTCF protein using the yeast two-hybrid system, pulldown and co-localization assays and have further analyzed the impact of CTSP-1 overexpression on the expression of CT genes mediated by CTCF and on the cell cycle progression. Using the CT antigen NY-ESO-1 as a model, we showed that the CTSP-1 overexpression does not alter the endogenous levels of NY-ESO-1 in the tumor cell line H1299. On the other hand, we observed that the overexpression of CTSP-1 in H1299 cells 48h after the transfections induces a cell cycle arrest in G0/G1 and reduces the clonogenic capacity of these cells by a mechanism dependent on the CTSP-1 expression levels. Similar results were not observed for cell clones stably overexpressing CTSP-1, suggesting that these clones have arisen from cells that managed to escape cell cycle arrest in G0/G1. Preliminary results suggest that the reduced clonogenic capacity of H1299 cells expressing CTSP-1 and analyzed 48h after the transfections is not associated with cell death by apoptosis


Asunto(s)
Neoplasias Testiculares/patología , Antígenos de Carbohidratos Asociados a Tumores , Apoptosis/fisiología , Ensayo de Unidades Formadoras de Colonias/métodos , Técnicas del Sistema de Dos Híbridos/instrumentación
5.
Biol Res ; 41(3): 261-70, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-19399339

RESUMEN

Several major vascular tissues, such as the aorta-gonad-mesonephros region (AGM), yolk sac, and fetal liver have been confirmed to possess hematopoietic function. Recently, the placenta has been demonstrated as another hematopoietic organ. However, it is not conclusive whether the placenta possesses hematopoietic ability. Therefore, we undertook a series of experiments to study the hematopoietic functions of placenta. Fetal blood circulation in the placenta is difficult to be eliminated and its interference in the study of placental hematopoiesis is inevitable. With the application of placental flushing, fetal blood contained in the placenta was eliminated. We then made the further study of placental hematopoiesis after the E12.5 placenta was flushed. Our studies showed that placental cells expressing Sca-1, CD117 and CD34 were mainly restricted to the embryonic vessels of E12.5 placenta. The results of fluorescence activated cell sorter (FACs) analysis and colony forming cells (CFC) assay demonstrated that both placenta and placental blood contained hematopoietic stem/progenitor cells (HS/PCs), including CFU-GMs, CFU-GEMMs, BFU-Es, and HPP-CFCs. The frequency of HS/PCs in the placenta was 2-3 times that of placental blood. Therefore, it is necessary to clear placental blood out of the placenta in the studies of the hematopoietic potential of placenta. The placenta still possessed the hematopoietic potential after the fetal blood is flushed out. These observations provide further evidences that the placenta is a hematopoietic organ, as has been proposed for other embryonic hematopoietic sites.


Asunto(s)
Separación Celular/métodos , Ensayo de Unidades Formadoras de Colonias/métodos , Sangre Fetal/citología , Células Madre Hematopoyéticas/citología , Placenta/citología , Animales , Femenino , Ratones , Ratones Endogámicos C57BL , Embarazo
6.
Biol. Res ; 41(3): 261-270, 2008. ilus, tab, graf
Artículo en Inglés | LILACS | ID: lil-511916

RESUMEN

Several major vascular tissues, such as the aorta-gonad-mesonephros región (AGM), yolk sac, and fetal liver have been confirmed to possess hematopoietic function. Recently, the placenta has been demonstrated as another hematopoietic organ. However, it is not conclusive whether the placenta possesses hematopoietic ability. Therefore, we undertook a series of experiments to study the hematopoietic functions of placenta. Fetal blood circulation in the placenta is difficult to be eliminated and its interference in the study of placental hematopoiesis is inevitable. With the application of placental flushing, fetal blood contained in the placenta was eliminated. We then made the further study of placental hematopoiesis after the El2.5 placenta was flushed. Our studies showed that placental cells expressing Sca-1, CD117 and CD34 were mainly restricted to the embryonic vessels of E12.5 placenta. The results of fluorescence activated cell sorter (FACs) analysis and colony forming cells (CFC) assay demonstrated that both placenta and placental blood contained hematopoietic stem/progenitor cells (HS/PCs), including CFU-GMs, CFU-GEMMs, BFU-Es, and HPP-CFCs. The frequency of HS/PCs in the placenta was 2-3 times that of placental blood. Therefore, it is necessary to clear placental blood out of the placenta in the studies of the hematopoietic potential of placenta. The placenta still possessed the hematopoietic potential after the fetal blood is flushed out. These observations provide further evidences that the placenta is a hematopoietic organ, as has been proposed for other embryonic hematopoietic sites.


Asunto(s)
Animales , Femenino , Ratones , Embarazo , Separación Celular/métodos , Ensayo de Unidades Formadoras de Colonias/métodos , Sangre Fetal/citología , Células Madre Hematopoyéticas/citología , Placenta/citología
7.
Br J Nutr ; 97(2): 307-14, 2007 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-17298699

RESUMEN

Protein-energy malnutrition is a syndrome in which anaemia together with multivitamin and mineral deficiency may be present. The pathophysiological mechanisms involved have not, however, yet been completely elucidated. The aim of the present study was to evaluate the pathophysiological processes that occur in this anaemia in animals that were submitted to protein-energy malnutrition, in particular with respect to Fe concentration and the proliferative activity of haemopoietic cells. For this, histological, histochemical, cell culture and immunophenotyping techniques were used. Two-month-old male Swiss mice were submitted to protein-energy malnutrition with a low-protein diet (20 g/kg) compared with control diet (400 g/kg). When the experimental group had attained a 20 % loss of their original body weight, the animals from both groups received, intravenously, 20 IU erythropoietin every other day for 14 d. Malnourished animals showed a decrease in red blood cells, Hb concentration and reticulocytopenia, as well as severe bone marrow and splenic atrophy. The results for serum Fe, total Fe-binding capacity, transferrin and erythropoietin in malnourished animals were no different from those of the control animals. Fe reserves in the spleen, liver and bone marrow were found to be greater in the malnourished animals. The mixed colony-forming unit assays revealed a smaller production of granulocyte-macrophage colony-forming units, erythroid burst-forming units, erythroid colony-forming units and CD45, CD117, CD119 and CD71 expression in the bone marrow and spleen cells of malnourished animals. These findings suggest that, in this protein-energy malnutrition model, anaemia is not caused by Fe deficiency or erythropoietin deficiency, but is a result of ineffective erythropoiesis.


Asunto(s)
Anemia/fisiopatología , Células Precursoras Eritroides/fisiología , Desnutrición Proteico-Calórica/fisiopatología , Anemia/sangre , Anemia/patología , Animales , Proteínas Sanguíneas/análisis , Peso Corporal/fisiología , Células de la Médula Ósea/patología , Ensayo de Unidades Formadoras de Colonias/métodos , Proteínas en la Dieta/administración & dosificación , Modelos Animales de Enfermedad , Eritropoyesis/fisiología , Eritropoyetina/administración & dosificación , Eritropoyetina/análisis , Citometría de Flujo/métodos , Inmunofenotipificación/métodos , Hierro/análisis , Hierro/sangre , Hierro/metabolismo , Masculino , Ratones , Desnutrición Proteico-Calórica/sangre , Desnutrición Proteico-Calórica/patología , Bazo/patología , Transferrina/metabolismo
8.
Braz J Med Biol Res ; 39(7): 901-6, 2006 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-16862281

RESUMEN

The total number of CD34+ cells is the most relevant clinical parameter when selecting human umbilical cord blood (HUCB) for transplantation. The objective of the present study was to compare the two most commonly used CD34+ cell quantification methods (ISHAGE protocol and ProCount - BD) and analyze the CD34+ bright cells whose 7-amino actinomycin D (7AAD) analysis suggests are apoptotic or dead cells. Twenty-six HUCB samples obtained at the Placental Blood Program of New York Blood Center were evaluated. The absolute numbers of CD34+ cells evaluated by the ISHAGE (with exclusion of 7AAD+ cells) and ProCount (with exclusion of CD34+ bright cells) were determined. Using the ISHAGE protocol we found 35.6 +/- 19.4 CD34+ cells/microL and with the ProCount method we found 36.6 +/- 23.2 CD34+ cells/microL. With the ProCount method, CD34+ bright cell counts were 9.3 +/- 8.2 cells/microL. CD34+ bright and regular cells were individually analyzed by the ISHAGE protocol. Only about 1.8% of the bright CD34+ cells are alive, whereas a small part (19.0%) is undergoing apoptosis and most of them (79.2%) are dead cells. Our study showed that the two methods produced similar results and that 7AAD is important to exclude CD34 bright cells. These results will be of value to assist in the correct counting of CD34+ cells and to choose the best HUCB unit for transplantation, i.e., the unit with the greatest number of potentially viable stem cells for the reconstitution of bone marrow. This increases the likelihood of success of the transplant and, therefore, the survival of the patient.


Asunto(s)
Antígenos CD34/sangre , Recuento de Células Sanguíneas/métodos , Ensayo de Unidades Formadoras de Colonias/métodos , Sangre Fetal/citología , Células Madre Hematopoyéticas/citología , Bancos de Sangre , Supervivencia Celular , Dactinomicina/análogos & derivados , Citometría de Flujo , Colorantes Fluorescentes , Humanos , Reproducibilidad de los Resultados
9.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;39(7): 901-906, July 2006. tab, graf
Artículo en Inglés | LILACS | ID: lil-431560

RESUMEN

The total number of CD34+ cells is the most relevant clinical parameter when selecting human umbilical cord blood (HUCB) for transplantation. The objective of the present study was to compare the two most commonly used CD34+ cell quantification methods (ISHAGE protocol and ProCount™ - BD) and analyze the CD34+ bright cells whose 7-amino actinomycin D (7AAD) analysis suggests are apoptotic or dead cells. Twenty-six HUCB samples obtained at the Placental Blood Program of New York Blood Center were evaluated. The absolute numbers of CD34+ cells evaluated by the ISHAGE (with exclusion of 7AAD+ cells) and ProCount™ (with exclusion of CD34+ bright cells) were determined. Using the ISHAGE protocol we found 35.6 ± 19.4 CD34+ cells/æL and with the ProCount™ method we found 36.6 ± 23.2 CD34+ cells/æL. With the ProCount™ method, CD34+ bright cell counts were 9.3 ± 8.2 cells/æL. CD34+ bright and regular cells were individually analyzed by the ISHAGE protocol. Only about 1.8 percent of the bright CD34+ cells are alive, whereas a small part (19.0 percent) is undergoing apoptosis and most of them (79.2 percent) are dead cells. Our study showed that the two methods produced similar results and that 7AAD is important to exclude CD34 bright cells. These results will be of value to assist in the correct counting of CD34+ cells and to choose the best HUCB unit for transplantation, i.e., the unit with the greatest number of potentially viable stem cells for the reconstitution of bone marrow. This increases the likelihood of success of the transplant and, therefore, the survival of the patient.


Asunto(s)
Humanos , /sangre , Recuento de Células Sanguíneas/métodos , Ensayo de Unidades Formadoras de Colonias/métodos , Sangre Fetal/citología , Células Madre Hematopoyéticas/citología , Bancos de Sangre , Supervivencia Celular , Dactinomicina/análogos & derivados , Citometría de Flujo , Colorantes Fluorescentes , Reproducibilidad de los Resultados
10.
Rev. bras. anal. clin ; 27(1): 19-24, 1995. ilus, tab, graf
Artículo en Portugués | LILACS | ID: lil-269352

RESUMEN

A detecçäo de progenitores hemopoiéticos da linhagem eritróide, BFU-E e CFU-E, envolveu a cultura de células mononucleares hemopoiéticas obtidas de medula óssea, sangue periférico e sangue de cordäo umbilical em meio de IMDM, suplementado com antibióticos, soro bovino fetal 25 porcento, soroalbumina bovina 1 porcento, meio condicionado da linhagem celular 5637 (como fonte exogena de fatores de crescimento) 1 porcento e adiçäo de eritropoietina humana recombinante em matriz semi-sólida (metilcelulose). Usando-se a técnica, populaçöes distintas de células progenitoras de linhagem eritróide puderam ser detectadas e definidas em sua linhagem pela capacidade de orientar colônias de aspecto característico, após um período de incubaçäo de 14-20 dias, à 37§C, em atmosfera úmida, com 5-19 porcento de CO2. Os tipos de colônias de BFU-E e CFU-E observados foram de tamanho variado, apresentado coloraçäo vermelha em tons variáveis. Células hemopoiéticas constituintes da linhagem eritróide, em diferentes graus de maturaçäo, foram morfologicamente identificadas após coloraçäo panóptica. A frequência de colônias de BFU-E e CFU-E observada, em nossos estudos foram, respectivamente: 33 mais ou menos 4,4 e 30,3 mais ou menos 5,4 para medula óssea; 12,7 mais ou menos 4,3 e 9,3 e 9,3 mais ou menos 1,5 para sangue periférico; 26,6 mais ou menos 8,7 e 25,6 mais ou menos 11 para sangue de cordäo umbilical


Asunto(s)
Humanos , Masculino , Femenino , Niño , Adolescente , Adulto , Células de la Médula Ósea , Células Madre , Células Precursoras Eritroides , Eritropoyetina/aislamiento & purificación , Sangre Fetal/citología , Ensayo de Unidades Formadoras de Colonias/métodos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA